Related Experiment Video

Updated: Aug 18, 2026

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
06:36

A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion

Published on: April 24, 2015

Growth factors and their relationship to neoplastic and paraneoplastic disease

R A Badawi1, J Birns, T Watson

  • 1Department of Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, United Kingdom.

European Journal of Internal Medicine
|April 19, 2005
PubMed

Insights

Growth factors regulate cell functions, and their dysregulation is linked to cancer. Targeting growth factor pathways, like with monoclonal antibodies, offers promising cancer therapies.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Oncology

Background:

  • Growth factors are key extracellular signaling molecules regulating cell growth, proliferation, differentiation, and survival.
  • Aberrant growth factor signaling networks are implicated in the molecular pathogenesis of neoplastic and paraneoplastic diseases.
  • Understanding growth factor mechanisms in cell cycling, division, and death is crucial for cancer research.

Purpose of the Study:

  • To explore the role of growth factors in cancer development.
  • To highlight therapeutic strategies targeting growth factor pathways.
  • To discuss the potential of molecularly targeted cancer therapies.

Main Methods:

  • Review of scientific literature on growth factor biology and cancer.
  • Analysis of specific examples like Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor (VEGF).
  • Discussion of therapeutic applications, including monoclonal antibodies.

Main Results:

  • Dysregulation of growth factor networks is a significant factor in cancer pathogenesis.
  • Targeting growth factors like EGF and VEGF has led to effective clinical therapies.
  • Monoclonal antibodies targeting growth factors demonstrate successful clinical applications.

Conclusions:

  • Growth factor biology provides a foundation for developing targeted cancer therapies.
  • Molecularly targeted oncological therapy represents a growing and effective approach to cancer treatment.
  • Harnessing growth factor mechanisms offers a rational strategy for future cancer therapeutics.

More Related Videos

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...